Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9 |
High Similarity |
NPD6959 |
Discontinued |
0.8571 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD7473 |
Discontinued |
0.8485 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8408 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.84 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8395 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8391 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8323 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8274 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8208 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8208 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8171 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8148 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8125 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8125 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8125 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8068 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.8059 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8059 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8023 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8013 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7946 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7946 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7946 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7917 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7917 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7911 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7911 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1607 |
Approved |
0.788 |
Intermediate Similarity |
NPD6778 |
Approved |
0.788 |
Intermediate Similarity |
NPD6781 |
Approved |
0.788 |
Intermediate Similarity |
NPD6776 |
Approved |
0.788 |
Intermediate Similarity |
NPD6782 |
Approved |
0.788 |
Intermediate Similarity |
NPD6777 |
Approved |
0.788 |
Intermediate Similarity |
NPD6780 |
Approved |
0.788 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7862 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7862 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7848 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7848 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7848 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7848 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7848 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7844 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7831 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7811 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7784 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7771 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7764 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7756 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7751 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7749 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7749 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7738 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7719 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7702 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7696 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7696 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7684 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7676 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7657 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7656 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7636 |
Intermediate Similarity |
NPD1512 |
Approved |
0.763 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7627 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7627 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7625 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7625 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7609 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7593 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7588 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7588 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7544 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7532 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7529 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7529 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7526 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7526 |
Intermediate Similarity |
NPD8319 |
Approved |
0.75 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7469 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7452 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7447 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7439 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7418 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD920 |
Approved |
0.7381 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7377 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7366 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7366 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7366 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7326 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7326 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7296 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7289 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7267 |
Intermediate Similarity |
NPD37 |
Approved |
0.7263 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7262 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7262 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7257 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7253 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7249 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7241 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7238 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7216 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD1247 |
Approved |
0.717 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.717 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7168 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7134 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7126 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7104 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7099 |
Intermediate Similarity |
NPD943 |
Approved |
0.7099 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7081 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7081 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD919 |
Approved |
0.7051 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD3300 |
Phase 2 |
0.7021 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7019 |
Intermediate Similarity |
NPD7654 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD8127 |
Discontinued |
0.6983 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6981 |
Remote Similarity |
NPD2797 |
Approved |
0.6981 |
Remote Similarity |
NPD1203 |
Approved |
0.6975 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4749 |
Approved |
0.6951 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1281 |
Approved |
0.6937 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6931
|
Remote Similarity |
NPD7930 |
Approved |